# Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

> **NCT06491108** · PHASE3 · RECRUITING · sponsor: **Tanta University** · enrollment: 150 (estimated)

## Conditions studied

- Enlarged Prostate With Lower Urinary Tract Symptoms

## Interventions

- **DRUG:** Vardenafil 5 Mg Oral Tablet

## Key facts

- **NCT ID:** NCT06491108
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-07-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06491108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06491108, "Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06491108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*